Key Takeaways
- Record quarter, margin spike temporary: Disbursements and book growth hit all-time highs, and NIM jumped to 4.15% from 3.74% QoQ, but management explicitly guided this is not sustainable and steady-state NIM will settle at 3.7% to 3.75%.
- Asset quality improved, but provisions were built proactively: GNPA fell to 0.64% from ~1% via recoveries, while PCR was deliberately hiked from 33.47% to 52.69% by adding ₹15 crores in provisions as a cushion against a possible COVID fourth wave.
- CEO and audit rumors denied head-on: The MD & CEO stated categorically he has not resigned and does not intend to move out, and an ongoing NHB audit has so far revealed nothing abnormal.
- Growth guided at 18-20% for FY23, funded by a capital raise that will dilute ROE: Disbursements are expected to cross ₹10,000 crores, and part of an enabling ₹1,000 crore equity raise will be executed in the next two to three quarters, which management acknowledged will impact ROE in the year of raising.
- What to watch next quarter: Whether NIM compresses toward the guided 3.7-3.75% steady state, the pace of the equity raise and its ROE impact, and whether the elevated 0.4% credit cost persists despite strong asset quality.
Margin Dynamics: The Spike and the Guided Normalization
- NIM spike driven by lagged rate increases and insurance income: Two rate increases from April last year had a positive lag effect on yields, while other income, particularly insurance, rose to ₹6 crores from ₹3.0-3.7 crores last quarter, pushing NIM to 4.15%.
- Spread improved QoQ but compressed YoY: Spread rose to 2.55% from 2.49% QoQ, but declined from 2.78% in Q4 last year because the portfolio repriced after COVID-era rate drops, and current market home loan rates of 7%-7.5% require a balance between profitability and growth.
- Cost of funds inched up as rates began rising: Incremental cost of funds was 5.03% in Q4, while portfolio cost was 5.56%; management expects rates to rise by 100-125 bps over the next one and a half years, which will push both yields and costs higher.
- Steady-state NIM guided down explicitly: Management stated the 4.15% NIM is not sustainable and expects it to settle around 3.7% to 3.75%, with spreads around 2.5%, as the portfolio fully reflects the current competitive rate environment.
- LCR positive carry adds a small tailwind: The company holds over ₹1,000 crores against a requirement of ~₹350 crores, contributing roughly 12 bps to NIM.
Kousgi: "No, no NIM is 4.15% I told going forward on a steady state NIM should settle around 3.7%."
Asset Quality: Clean-Up via Recoveries, Cushion Built Proactively
- GNPA reduction driven entirely by recoveries, not upgrades: GNPA fell from ~1% to 0.64% because recoveries from the NPA pool via SARFAESI action, OTS, and very few reversals were much higher than new flows from SMA-2 to NPA; upgradation was very low.
- PCR deliberately hiked as a precautionary buffer: Management added ₹15 crores in provisions this quarter, lifting PCR from 33.47% to 52.69%, citing uncertainty about a COVID fourth wave and the fact that overall performance was good enough to build a cushion.
- Restructured book performing fully: The ₹676 crore restructured book has 100% collection on fallen-due EMIs, and ₹1.69 crores was written back from provisions this quarter; the book has shrunk by ₹42 crores, and the initial estimate of ~7% flowing to NPA (~₹49 crores) remains unchanged.
- Credit cost elevated at 0.4%, partly by design: The 0.4% credit cost, up from 0.36% earlier, reflects the deliberate PCR increase and provisioning on a growing standard asset book; management expects it to remain around this level, possibly settling between 0.35% and 0.4% over time as the portfolio matures.
- Internal fraud identified at one branch: An internal audit found ₹3.93 crores of fraud at the Bhilwara branch involving fake income tax returns.
Kousgi: "we are not very sure about COVID fourth wave and we thought so that when we are doing well, let's you know, create some amount of provision so that we might take a call in future"
Growth and Demand: Record Disbursements, Broad-Based Recovery
- All-time high disbursements and book growth: Q4 was the strongest quarter in company history, with full-year disbursements growing ~90% YoY and Q4 YoY growth at 35%; four of the last five quarters were good after the COVID second wave hit Q1.
- SENP mix recovered sharply: The self-employed/non-professional share, which had dropped to ~12% during COVID, recovered to ~28% as confidence and economic activity improved; management expects a return to the 70% salaried / 30% self-employed mix in a quarter or two.
- Balance transfer outflows normalized: BT out dropped from ₹543 crores in FY21 to ₹293 crores in FY22, back to pre-COVID levels, driven by a strong customer retention team and aggressive retention strategy.
- Demand strong across most geographies: South (Karnataka, Andhra, Telangana), Maharashtra, Gujarat, and MP all showed good demand; only Delhi NCR was slightly slow. Karnataka dependency has reduced from ~1/3 to ~25-25.5% as other states contribute more.
- Competition back to normal from January: Banks were unusually aggressive on balance transfers during COVID, but from January onwards competition returned to business-as-usual levels.
- Ticket size stabilizing: Average ticket size is stable at ₹21 lakhs, up from ₹18 lakhs earlier, with limited scope for further increase; expected to stabilize at ₹21-22 lakhs.
Kousgi: "From January onwards, it is back to normal. So, from January competition is back to normal which is the business as usual for us."
Capital Raise: Growth Fuel with an ROE Acknowledgment
- Enabling approval for up to ₹1,000 crores obtained: Part of this amount will be raised in the next two to three quarters, not the entire amount in the first tranche.
- Rationale is future growth and DER reduction: Management stated the raise will support future growth and bring down DER, even though capital adequacy is comfortable at 23.3% (100% Tier-1) and DER comfort is up to 8.5x.
- ROE dilution acknowledged: Management conceded the equity raise will have some impact on ROE in the year of raising, but argued it will enable growth from the next year onward.
- An analyst questioned the logic: Given high capital adequacy and DER headroom, the apparent contradiction between ample capital and the need for equity was not fully resolved on the call.
Kousgi: "I understand we have been engaging with all the bankers. Obviously, we also were pretty comfortable now DER of up to 8.5x and therefore we also had a backup plan. One is if you look at capital adequacy, we are at comfortable level, but we thought of raising capital, no thinking in mind that one, it will help us to be in future in terms of growth and number two also to try and bring down DER."
Operations and Efficiency: IT Overhaul and Productivity Levers
- IT infrastructure transformation underway: The entire lending and deposit systems are being changed over 12-15 months, with API integrations, scan-based approval, and AI-driven pre-screening; the PERFIOS tool has already cut bank statement analysis time for self-employed applicants from ~2 hours to ~3 minutes.
- Productivity metrics improved: Average business per employee rose from ₹27.6 crore in Q3 to ₹29.97 crore in Q4; average business per branch improved from ₹127 crores to ₹136 crores.
- Cost-to-income elevated by investment spend: Other operating costs rose sharply QoQ driven by IT transformation spend, PSR, and DSA commissions linked to higher disbursements; employee costs fluctuated due to a once-in-five-years salary revision with arrears.
- Branch network has headroom: Management believes existing branches can support a book of close to ₹40,000 crores through deeper penetration and productivity gains, though new branches will also be opened.
- Processing TAT expected to halve: Automation from the IT transformation is expected to reduce turnaround time by at least 50%.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Steady-state NIM | Settle in the range of 3.7% to 3.75% | Going forward (no specific quarter) |
| Steady-state spread | Around 2.5% | Going forward |
| Credit cost | Remain at ~0.4%, possibly settling to 0.35-0.4% over time | Full year FY23; may moderate after a couple more quarters |
| FY23 disbursements | ₹10,000 crores plus | FY2023 |
| FY23 portfolio growth | 18% to 20% | FY2023 |
| Portfolio mix | Return to 70% salaried / 30% self-employed | In a quarter or two |
| Capital raise | Part of the ₹1,000 crore enabling approval to be raised | Next two to three quarters |
| IT transformation completion | Lending and deposit system overhaul | 12-15 months |
| Processing TAT reduction | At least 50% reduction from automation | Over the IT transformation period |
| CP share in borrowings | Stabilize around 15-16% | Ongoing |
| Cost-to-income ratio | Moderate to around 17%-18% | As investment spend normalizes |
| Ticket size | Stabilize at ₹21-22 lakhs | Ongoing |
| Insurance income growth | Around 20% growth | Ongoing |
Key Metrics
| Metric | Q4 FY22 |
|---|---|
| NIM | 4.15%, up from 3.74% QoQ; includes 12 bps from LCR investment |
| NIM net of LCR | 4.03% |
| Spread | 2.55%, improved from 2.49% QoQ |
| Portfolio yield | 8.11% |
| Incremental yield | 8.07% |
| Portfolio cost of funds | 5.56% |
| Incremental cost of funds | 5.03% |
| GNPA | 0.64%, down from 0.71% QoQ |
| Net NPA | ~0.3%, down from 0.61% QoQ |
| PCR | 52.69%, up from 33.47% QoQ |
| Credit cost | 0.4% |
| Book growth | ~21% YoY |
| Q4 disbursement growth | 35% YoY |
| Full-year disbursement growth | ~90% YoY |
| Disbursements guidance FY23 | ₹10,000 cr plus |
| Growth guidance FY23 | 18% to 20% |
| Spread guidance (steady state) | ~2.5% |
| NIM guidance (steady state) | 3.7% to 3.75% |
| Cost to income ratio | ~20%, expected to moderate to 17%-18% |
| Average ticket size | ₹21 lakhs |
| Portfolio mix: HL / Non-HL | 90% / 10% (top-up 4%, LAP 4%, site loan 1%, others 1%) |
| Portfolio profile: Salaried / SENP | 72% / 28% |
| SENP incremental share | ~28%, recovered from ~12% during COVID |
| Average business per employee | ₹29.97 cr, up from ₹27.6 cr in Q3 |
| Average business per branch | ₹136 cr, up from ₹127 cr in Q3 |
| Branches | 187 |
| Total employees | a little over 900 |
| Balance transfer out (full year) | ₹293 cr, down from ₹543 cr last year |
| Insurance income | ₹6 cr, up from ₹3.0-3.7 cr QoQ |
| Restructured book outstanding | ₹676 cr |
| Restructured book provisioning | ₹67 cr (10% of outstanding) |
| Standard asset provisioning | ₹98 cr |
| Total provisions held | ₹270 cr |
| Stage-1 assets | ₹25,268 cr |
| Stage-2 assets | ₹1,270 cr, down from ₹1,652 cr in December |
| Stage-3 assets | ₹170 cr |
| Provision on Stage-2 | 34.88% |
| Capital adequacy | 23.3%, 100% Tier-1 |
| Tier-2 capital | ₹100 cr |
| Liability mix: Banks / NHB / NCD / CP / Deposits | 51% / 22% / 14% / 11% / 2% |
| CP share expected to stabilize | 15-16% |
| Funds raised in Q4 | ₹3,215 cr |
| Outstanding borrowings | ₹24,600 cr |
| Liquidity (unavailed bank sanctions) | ~₹4,300 cr |
| LCR held | more than ₹1,000 cr, requirement ~₹350 cr |
| Average LTV (portfolio level) | ~67% |
| Average loan tenure on book | 8.5-9 years |
| Karnataka loan book share | ~25-25.5%, down from ~33% earlier |
| Bangalore incremental business share | 23-24% |
| Equity capital raise approval | up to ₹1,000 cr, part to be raised in 2-3 quarters |
| Identified fraud (Bhilwara branch) | ₹3.93 cr |